Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine plus mannitol for acute pancreatitis with intra-abdominal hypertension or abdominal compartment syndrome
ChiCTR-IPR-15006580Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jun 2015
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of neostigmine and Bronchitol in acute pancreatitis (AP) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Intra-abdominal pressure. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
neostigmineBronchitol
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-IPR-15006580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006580.